tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Advertisement

Gain Therapeutics (GANX) Ownership - Who Owns Gain Therapeutics?

Compare
273 Followers

Gain Therapeutics (GANX) Ownership Overview

3.70%1.46%0.08%1.70%93.07%
0.08% Other Institutional Investors
1.70% ETFs
93.07% Public Companies and
Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 3.23% of the company’s stock is owned by Institutional Investors, 3.70% is owned by Insiders, and 93.07% is owned by Public Companies and Individual Investors.
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 1.53% of the company’s stock is owned by Institutional Investors, 3.70% is owned by Insiders, and 1.70% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 12, 2024
xxxxxxxxxxxxx
$49500
Aug 12, 2024
xxxxxxxxxxxxx
$14544

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
930,784Insider2.69%1,475,293
524,837Institution1.52%831,867
304,458Insider0.88%482,566
245,475Institution0.71%389,078
227,128Institution0.66%359,998
158,155Institution0.46%250,676
61,595Institution0.18%97,628
30,004Institution0.09%47,556
30,000Insider0.09%47,550
14,400Insider0.04%22,824

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
245,475Institution0.71%389,078
227,128Institution0.66%359,998
30,004Institution0.09%47,556
1,011Institution<0.01%1,602
486Institution<0.01%770

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
524,837Institution1.52%944,707
64,080Institution0.19%101,567

FAQ

Who Owns Gain Therapeutics (GANX)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 3.70% is held by insiders, and 93.07% is held by retail investors.
    What percentage of Gain Therapeutics (GANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.08% of Gain Therapeutics (GANX) stock is held by institutional investors.
      What percentage of Gain Therapeutics (GANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 93.07% of Gain Therapeutics (GANX) stock is held by retail investors.
        Who owns the most shares of Gain Therapeutics (GANX)?
        Khalid Islam owns the most shares of Gain Therapeutics (GANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis